Concepedia

Su Yan

SY

14

Publications

755

Citations

13

H-Index

2005

Active since

Affiliations

Eureka Therapeutics (United States)(Current)

Cornell University

Chongqing Medical University

First Affiliated Hospital of Soochow University

Memorial Sloan Kettering Cancer Center

Su Yan is an author at Eureka Therapeutics (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyPathologyEngineeringPharmacologyCancer BiologyCancer ResearchGliomaOncology

Publications per year

2005–2023

14

Publications

14

Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids

Ambra Pozzi, Ines Macias‐Perez, Tristin D. Abair et al. · Journal of Biological Chemistry · 2005 · 180 citations · Full text

Lipid Analysis, Chemoprevention Strategy, Lipid Peroxidation +19

Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

Tao Dao, Su Yan, Nicholas Veomett et al. · Science Translational Medicine · 2013 · 178 citations

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy

Guilly Rebagay, Su Yan, Cheng Liu et al. · Frontiers in Oncology · 2012 · 78 citations · Full text

Engineering, Pathology, Cancer Biology +17

MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling

Bo Tang, Aoshuang Xu, Jian Xu et al. · International Journal of Cancer · 2017 · 76 citations

A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias

Leonid Dubrovsky, Dmitry Pankov, Elliott J. Brea et al. · Blood · 2014 · 50 citations · Full text

Rows per page

1–5 of 14